The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.
about
More than what the eye can see: the emotional journey and experience of powerlessness of integrated care service users and their carersRecovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment.Cancer patients' effort to return to normal life: a hermeneutic study.Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
P2860
The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The patient journey in chronic ...... global ethnographic approach.
@en
type
label
The patient journey in chronic ...... global ethnographic approach.
@en
prefLabel
The patient journey in chronic ...... global ethnographic approach.
@en
P2093
P2860
P921
P1476
The patient journey in chronic ...... global ethnographic approach.
@en
P2093
Ari Shapiro
Christina Bender
François Guilhot
John Coombs
Marc Paolantonio
Nancy J Macdonald
Oleg Zernovak
Tomasz Szczudlo
P2860
P2888
P356
10.1007/S40271-013-0006-3
P577
2013-01-01T00:00:00Z
P6179
1029969180